APA

Eckstein N., Servan K., Hildebrandt B., Pölitz A., von Jonquières G., Wolf-Kümmeth S., Napierski I., Hamacher A., Kassack M. U., Budczies J., Beier M., Dietel M., Royer-Pokora B., Denkert C. & Royer H. (20090602). Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. : Cancer research.

Chicago

Eckstein Niels, Servan Kati, Hildebrandt Barbara, Pölitz Anne, von Jonquières Georg, Wolf-Kümmeth Sybille, Napierski Inge, Hamacher Alexandra, Kassack Matthias U, Budczies Jan, Beier Manfred, Dietel Manfred, Royer-Pokora Brigitte, Denkert Carsten and Royer Hans-Dieter. 20090602. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. : Cancer research.

Harvard

Eckstein N., Servan K., Hildebrandt B., Pölitz A., von Jonquières G., Wolf-Kümmeth S., Napierski I., Hamacher A., Kassack M. U., Budczies J., Beier M., Dietel M., Royer-Pokora B., Denkert C. and Royer H. (20090602). Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. : Cancer research.

MLA

Eckstein Niels, Servan Kati, Hildebrandt Barbara, Pölitz Anne, von Jonquières Georg, Wolf-Kümmeth Sybille, Napierski Inge, Hamacher Alexandra, Kassack Matthias U, Budczies Jan, Beier Manfred, Dietel Manfred, Royer-Pokora Brigitte, Denkert Carsten and Royer Hans-Dieter. Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells. : Cancer research. 20090602.